Huberman LabDr. Tony Wyss-Coray on Huberman Lab: How blood resets aging
Parabiosis cut inflammation in aged mice via young blood factors; blood protein panels now assign organ age gaps that predict disease risk years before.
CHAPTERS
- 0:00 – 4:38
Young blood & parabiosis: reactivating brain stem cells and restoring memory
Wyss-Coray and Huberman open with the core rejuvenation finding: factors from young organisms can measurably reverse aspects of brain aging in old mice. They discuss parabiosis (shared circulation between young and old mice) and the striking outcomes—reactivated neural stem cells, reduced inflammation, altered neural activity, and improved memory.
- •Parabiosis as a method to test causality (young circulation → old tissue changes)
- •Evidence for reactivated brain stem cells and reduced neuroinflammation in old mice
- •Improved neural activity measures and memory performance after exposure to young factors
- •Framing blood not just as a ‘readout’ of health, but as a source of active signaling molecules
- 4:38 – 15:22
From Alzheimer's blood signatures to human translation: plasma fractions & early trials
The conversation shifts from animal findings to human relevance, starting with the observation that blood protein profiles differ dramatically between young vs. old people and can relate to Alzheimer’s risk. Wyss-Coray describes efforts to translate these findings through plasma fractionation, collaborations with plasma-medicine manufacturers, and early Alzheimer’s/Parkinson’s infusion trials.
- •Human blood protein differences by age were among the strongest signals in Alzheimer’s biomarker work
- •Injecting human ‘young’ vs ‘old’ plasma into mice shows conserved effects across species
- •Testing specific plasma fractions (e.g., albumin-containing) to identify the most active components
- •Small human trials in Alzheimer’s/Parkinson’s plus larger therapeutic plasma exchange studies suggesting benefit
- 15:22 – 20:15
What’s actually in “young blood”: removing ‘bad’ inflammatory signals vs adding ‘good’ growth factors
Huberman presses on mechanism: do rejuvenation effects come from eliminating harmful age-related factors, or from adding youth-promoting ones? Wyss-Coray explains it’s both—aging blood accumulates inflammatory proteins that can be blocked, while youth also contains pro-growth signals—and highlights the challenge of identifying the minimal effective ‘cocktail.’
- •Aging increases inflammatory proteins; neutralizing some can improve cognition in old mice
- •Youthful blood also contains pro-growth factors that support cell function and stem cells
- •Different cell types respond differently due to distinct receptor landscapes
- •Pinpointing causative factors is hard; may require systematic gene knockout/CRISPR-style approaches
- 20:15 – 23:52
Blood banking, Dracula lore, and why ‘drink young blood’ isn’t the mechanism
They address popular myths: whether one should bank their own young blood and how cultural stories like Dracula might have emerged. Wyss-Coray notes research uses pooled donor plasma (not individualized banking) and emphasizes that oral consumption of blood has not been studied as a rejuvenation approach.
- •Personal blood banking is likely unnecessary for these approaches; pooled young plasma can work experimentally
- •Dracula/blood mythology likely reflects recognition of blood’s essential role, not scientific practice
- •No evidence for benefits of ingesting blood; proteins would need to survive digestion and be absorbed
- •Historical practices like leeching may have had effects via anticoagulants/secreted factors, but not ‘youth transfer’
- 23:52 – 28:27
Organ-specific aging: protein-based ‘organ clocks,’ age gaps, and disease-risk prediction
Wyss-Coray explains that organs do not age in perfect synchrony and introduces protein-based organ aging models built from large human cohorts. The key concept is the ‘age gap’—when an organ appears older than chronological age—which strongly predicts future disease risk in that organ (heart, kidney, brain, etc.).
- •Different tissues show distinct aging trajectories (stable periods vs early decline vs late collapse)
- •Blood contains organ-derived proteins that can be used to estimate organ biological age
- •‘Age gap’ (estimated organ age minus chronological age) predicts future organ-specific disease risk
- •Conceptual shift: using organ-age measures to target prevention earlier and more precisely
- 28:27 – 33:02
Vero Biosciences: tailoring therapies using organ aging + clinical and wearable data
Building on organ clocks, Wyss-Coray describes a platform approach that integrates proteomics with clinical variables and wearable data to recommend individualized interventions. The goal is continuous monitoring—identify vulnerable organs, apply specific therapies or lifestyle changes, and retest to verify response.
- •Combining organ-age biomarkers with clinical history and wearable outputs
- •Closed-loop model: test → intervene (drug/lifestyle) → retest to confirm organ-age response
- •Potential application: better stratification for complex diseases like Alzheimer’s (subtypes, timing)
- •Addresses why some drugs may ‘fail’ in broad trials but help specific risk-profile subgroups
- 33:02 – 36:44
NAD, NMN/NR supplements: what we know, what we don’t, and supplement quality pitfalls
Huberman raises the controversy around NAD-boosting strategies (NMN/NR/NAD infusions) and their claims for longevity. Wyss-Coray emphasizes that no human intervention has proven lifespan extension, notes that some studies show blood-level increases, and warns about supplement instability and label inaccuracy.
- •No validated human intervention has been shown to extend lifespan in rigorous trials
- •NMN/NR can raise measured blood levels, but outcome benefits (frailty, healthspan, lifespan) remain unproven
- •High variability and quality-control issues in supplements; some products may not match labels
- •Practical advice: if using supplements, prioritize reputable sources and third-party testing
- 36:44 – 47:28
Vitality vs longevity: antagonistic pleiotropy and ‘waves’ of accelerated aging
They explore trade-offs between interventions that increase youthful vitality (e.g., growth hormone/IGF-1) and those that might extend lifespan. Wyss-Coray introduces antagonistic pleiotropy (youth-beneficial pathways can become harmful later) and discusses nonlinear ‘waves’ of aging, including major shifts around the late 30s.
- •Vitality-boosting hormones can have lifespan trade-offs (IGF-1/growth pathways)
- •Antagonistic pleiotropy: what helps early life can harm later-life healthspan
- •Aging is nonlinear, with identifiable inflection ‘waves’ (notably around ~35–40)
- •Modern longevity gains largely come from hygiene, antibiotics, and disease management—not true rejuvenation
- 47:28 – 53:58
Exercise as a transferable ‘blood therapy’: liver-to-brain factors (clusterin), intensity signals (Lac-Phe)
Wyss-Coray describes experiments showing that blood from exercised animals can transfer brain benefits to sedentary animals, sometimes exceeding ‘young blood’ alone. They discuss specific candidates like clusterin (apolipoprotein J) and broader implications: different exercise types may produce distinct molecular signals, possibly explaining divergent longevity outcomes across athletic profiles.
- •Exercise benefits can be transmitted through blood plasma in animal models
- •Liver-derived factors appear central in signaling to the brain; clusterin is a key candidate
- •Exercised-young blood can outperform non-exercised young blood in some paradigms
- •Different exercise modes may generate distinct metabolites (e.g., Lac-Phe) and different brain/body benefits
- 53:58 – 1:05:43
Injury, inflammation, stem-cell and ‘rejuvenation’ clinic risks; PRP and exosomes explained
Discussion turns to why healing slows with age (immune/inflammation shifts and extracellular matrix changes) and the dangers of unregulated interventions. Huberman shares a cautionary stem-cell injection story; Wyss-Coray emphasizes the need for controlled trials. They contrast this with PRP (growth-factor rich, autologous) and clarify what exosomes are and why they’re being explored.
- •Aging shifts immunity toward chronic inflammation and poorer regenerative responses; ECM changes may impede healing
- •Unregulated stem-cell injections can carry severe infection/complication risks; clinical rigor is essential
- •PRP: concentrated platelets from one’s own blood delivering growth factors used in injury contexts
- •Exosomes: vesicles carrying proteins/RNA/lipids; potential for diagnostics and therapeutics, but clinical evidence varies
- 1:05:43 – 1:12:59
Accumulated exposures & modern environment: smoking, plastics, EMFs, fresh food, and practical realism
They cover cumulative risk factors that degrade healthspan—smoking as a clear negative, and the harder-to-quantify long-term effects of plastics, chemicals, and EMFs. Both emphasize uncertainty and the difficulty of isolating variables, while highlighting pragmatic steps like prioritizing fresh, home-prepared foods when possible.
- •Smoking is strongly linked to DNA damage, inflammation, and reduced lifespan
- •Long-term low-level exposures (plastics/chemicals/EMFs) are hard to quantify; accumulation and combinations may matter
- •Avoiding everything can become impractical; focus on controllable, high-leverage behaviors
- •Fresh, minimally processed foods and cooking at home as a realistic ‘cleaner’ baseline strategy
- 1:12:59 – 1:59:13
Fasting, sleep, CSF biomarkers, and cognitive resilience; plus breathing, light, and future directions
Wyss-Coray gives a cautious view on fasting—definitions vary, animal results don’t always translate, and human outcome trials are limited—while agreeing that constant snacking is likely maladaptive. They discuss sleep and brain fluids, including Wyss-Coray’s CSF work identifying synaptic protein patterns that predict cognitive resilience, and they brainstorm measurable lifestyle mechanisms (breathing, sunlight/light at night). The episode closes with his newest projects: cell-type-specific aging clocks and a proteomic map of monogenic diseases.
- •Fasting: no universal definition; mixed translation from animal to humans, and some primate data suggest harms in certain contexts
- •Sleep and brain fluids: CSF composition changes with age; CSF synaptic protein ratios strongly predict cognitive resilience/decline
- •Mechanism-focused lifestyle ideas: deliberate breathing, bright days/dark nights, wearables as measurement tools
- •Future research: cell-type aging models (e.g., muscle-cell aging predicting ALS risk) and large-scale proteomic atlases for genetic diseases
